Dr. Ramirez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Robert Ramirez, DO, FACP
Dr. Robert Ramirez is a thoracic and neuroendocrine oncologist at Vanderbilt University Medical Center in Nashville, TN and Associate Professor of Medicine. He earned his medical degree from the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. He completed an internal medicine residency at Cooper University Hospital in Camden, New Jersey. He then completed a combined hematology and medical oncology fellowship at the University of Tennessee Health Sciences Center in Memphis, Tennessee where he served as chief fellow. He is a Fellow of the American College of Physicians (FACP) and a member of American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), and the North American Neuroendocrine Tumor Society (NANETS). He is a member of the Communications Committee for the IASLC and is a member of the Nominating as well as the Scientific Review and Research Committees for NANETS.
His clinical and research interests include neuroendocrine tumors (NETs) and lung cancer. He has a specific interest in NETs of the lung, diffuse idiopathic pulmonary neuroendocrine hyperplasia (DIPNECH) and high-grade neuroendocrine carcinomas. He is active in clinical trial design including investigator-initiated trials.
Education & Training
- University of TennesseeFellowship, Hematology and Medical Oncology, 2008 - 2011
- Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 2005 - 2008
- Rowan University School of Osteopathic MedicineClass of 2004
- Oakland UniversityB.A., Biology, Cum Laude, 2000
- Oakland Community CollegeAssociate of Arts, Liberal Arts, 1999
Certifications & Licensure
- TN State License 2008 - 2025
- NH State License 2024 - 2024
- FL State License 2020 - 2022
- LA State License 2012 - 2022
- MS State License 2020 - 2021
- AL State License 2020 - 2020
- AZ State License 2020 - 2020
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Resident/Fellow Reseach Mentor of the Year Ochsner Medical Center, 2017
- Travel Award North American Neuroendocrine Tumor Society Annual Meeting, 2013
- Merit Award American Society of Clinical Oncology Annual Meeting, 2011
- Join now to see all
Clinical Trials
- A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System Start of enrollment: 2018 Nov 05
- Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma Start of enrollment: 2019 Oct 02
Publications & Presentations
PubMed
- The developing role of theranostics in NETs.Robert A Ramirez, Cathy Eng
Lancet. 2024-06-29 - A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboringrearrangement.Wenbin Hu, Jiaming Zhao, Guoxia Wang, Qihao Wang, Mingming Deng
Translational Lung Cancer Research. 2024-05-31 - Making progress against rare cancers: A case study on neuroendocrine tumors.Michael O'Rorke, Elizabeth Chrischilles,
Cancer. 2024-05-01
Journal Articles
- Liver needle biopsies are poor predictors of histologic tumor grade for midgut neuroendocrine tumorsRamirez, RA, Beyer, DT, Wang, YZ, Oliva, I, Voros, B, Kokodis, I, Thiagarajan, R, Ricks, MJ, Bren-Mattison, Boudreaux, JP, Wang, YZ, Woltering, EA, Clinical Oncology Research, 1/31/2020
- Lung cancer in HIV-infected patients and the role of targeted therapyRuiz, M, Ramirez, RA, J Community and Supportive Onc, 8/2015
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: A single center experienceA. Chauhan, R.A. Ramirez, Lung, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Incidence of nodal positivity in appendiceal neuroendocrine tumors and its effect on survival.E.A. Woltering, D.T. Beyer, R. Thiagarajan, Y.Z. Wang, R.A. Ramirez, J.P. Boudreaux, 2015 North American Neuroendocrine Tumor Society Annual Meeting, Austin, TX, 1/16/2015
- Is surgical cytoreduction for stage IV pancreatic neuroendocrine tumors justifiable.Y.Z. Wang, E. McCord, M.A. Stevens, A.E. Diebold, R.A. Ramirez, J.P. Boudreaux, E.A. Woltering, 2015 North American Neuroendocrine Tumor Society Annual Meeting, Austin, TX, 1/16/2015
- The role of capecitabine/temozolomide (CAPTEM) in metastatic neuroendocrine tumors: A neuroendocrine tumor program experience.R.A.Ramirez, A. Chauhan, D.T. Beyer, J.P. Boudreaux, Y.Z. Wang, E.A. Woltering, 2015 North American Neuroendocrine Tumor Society Annual Meeting, Austin, TX, 1/16/2015
- Join now to see all
Lectures
- A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade ...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Update on the Medical Management of Neuroendocrine TumorsBaton Rogue, LA, 2015; New Orleans, LA, 2015 - 1/27/2015
- Neuroendocrine tumors of the lungNew Orleans, LA - 1/11/2015
- Join now to see all
Press Mentions
- Targeted Therapy for Neuroendocrine TumorsFebruary 16th, 2023
- New Clinician Spotlight: Robert RamirezApril 5th, 2021
- Gene Mutations Dictate Treatment in NCI Clinical TrialJuly 5th, 2018
- Join now to see all
Professional Memberships
- International Association for the Study of Lung CancerMember
- Member
- Fellow
- North American Neuroendocrine Tumor SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: